decisionhealth Newsletters, Coder Pink Sheets - 2007 Issue 1 (January)
Medicare says compounded drug pricing is up to carriers
Subscribe or sign in to view the full article.
Article Overview
This article discusses Medicare’s approach to compounded drug pricing under Part B, including the role of local carriers in pricing and reporting. It is relevant to coders, billing staff, and practices that bill compounded medications, especially when carrier-specific instructions and payment methodology may affect claims processing. The article also references CMS transmittal guidance and the use of certain HCPCS drug reporting conventions.
Why This Topic Matters
Compounded drug claims can be processed differently depending on the contractor, the reporting format, and whether the medication is treated as a compounded product or as a separately payable drug. Understanding the Medicare guidance helps reduce claim errors and support correct submission under carrier policy.
What You Will Learn
- How Medicare addresses pricing for compounded drugs under Part B
- Why carrier-specific instructions matter for compounded drug claims
- What types of reporting information may be required for manually priced compounded medications
- How CMS transmittal guidance relates to compounded drug billing
- Which general billing considerations may apply to pump refills and DME-related drug claims
Who Should Read This
- Medical coders
- Billing specialists
- Practice managers
- Durable medical equipment billing staff
- Pharmacy billing staff
Codes Discussed
Modifiers Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com